EUVIMEDEUVIMED entdecken
Crossref

The use of aprepitant for the prevention of postoperative nausea and vomiting in endoscopic transsphenoidal pituitary surgery

Daniel J Lee iD, Jennifer E Douglas iD, Jeremy Chang, Jadyn Wilensky, Christina Jackson, John Y K Lee, Michael Sean Grady, Daniel Yoshor, Michael A Kohanski, James N Palmer, Joshua H Atkins, Nithin D Adappa

International Forum of Allergy & Rhinology · 2023-12 · 13 (12) · 2180-2186

DOI: 10.1002/alr.23208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 26.06.2023. Verfasst von Daniel J Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head & Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Antiemetics, Pituitary Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postoperative nausea and vomiting (PONV) are adverse effects after surgery, which may increase the risk of complications. Aprepitant is a neurokinin‐1 receptor blocker and has been shown to reduce chemotherapy‐related nausea and vomiting and PONV. However, its role in endoscopic skull base surgery remains unclear. The purpose of this study was to evaluate the effect of aprepitant in reducing PONV in endoscopic transsphenoidal (TSA) pituitary surgery.

Methods

A retrospective chart review between July 2021 and January 2023 of 127 consecutive patients who underwent TSA was performed at a tertiary academic institution. Patients were divided into 2 groups based on preoperative aprepitant use. Two groups were matched based on known risk factors of PONV (age, sex, nonsmoking, and history of PONV). The primary outcome was the incidence of PONV. Secondary outcome measures included the number of anti‐emetic use, length of stay, and postoperative cererebrospinal fluid (CSF) leak.

Results

After matching, 48 patients were included in each group. The aprepitant group demonstrated a significantly lower incidence of vomiting than the non‐aprepitant group (2.1% vs 22.9%, p = 0.002). The number of nausea episodes and anti‐emetic use decreased with aprepitant use ( p < 0.05). There was no difference in the incidence of nausea, length of stay, or postoperative CSF leak. Multivariate analysis demonstrated that aprepitant decreased the incidence of postoperative vomiting with odds ratio of 0.107.

Conclusion

Aprepitant may serve as a useful preoperative treatment to reduce PONV in patients undergoing TSA. Further studies are needed to evaluate its impact in other arenas of endoscopic skull base surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntiemeticsPituitary DiseasesHumansAprepitantPostoperative Nausea and VomitingRetrospective StudiesMorpholines

Stichwörter der Autor:innen

aprepitantendoscopic skull base surgeryendoscopic transsphenoidal surgerypostoperative nauseapostoperative vomiting

Substanzen

AprepitantAntiemeticsMorpholines

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head & Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Daniel J Lee, Jennifer E Douglas

Zitieren

APA

Lee, D. J., Douglas, J. E., Chang, J., Wilensky, J., Jackson, C., Lee, J. Y. K., Grady, M. S., Yoshor, D., Kohanski, M. A., Palmer, J. N., Atkins, J. H., & Adappa, N. D. (2023). The use of aprepitant for the prevention of postoperative nausea and vomiting in endoscopic transsphenoidal pituitary surgery. International Forum of Allergy & Rhinology, 13(12), 2180-2186. https://doi.org/10.1002/alr.23208

Vancouver

Lee DJ, Douglas JE, Chang J, Wilensky J, Jackson C, Lee JYK, et al. The use of aprepitant for the prevention of postoperative nausea and vomiting in endoscopic transsphenoidal pituitary surgery. International Forum of Allergy & Rhinology. 2023;13(12):2180-2186. doi:10.1002/alr.23208

BibTeX
@article{Lee2023,
  author = {Lee, Daniel J and Douglas, Jennifer E and Chang, Jeremy and Wilensky, Jadyn and Jackson, Christina and Lee, John Y K and Grady, Michael Sean and Yoshor, Daniel and Kohanski, Michael A and Palmer, James N and Atkins, Joshua H and Adappa, Nithin D},
  title = {The use of aprepitant for the prevention of postoperative nausea and vomiting in endoscopic transsphenoidal pituitary surgery},
  journal = {International Forum of Allergy & Rhinology},
  year = {2023},
  volume = {13},
  number = {12},
  pages = {2180--2186},
  doi = {10.1002/alr.23208}
}
Kostenlos starten →